The Impact of IV Iron on Exercise Capacity and Quality of Life in Pulmonary Hypertension

NCT07359599 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

306

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension
Iron Deficiency

Interventions

DRUG: Ferric Carboxymaltose (FCM)
DRUG: Sodium Chloride (NaCl) 0.9 %

Sponsor

Ziekenhuis Oost-Limburg

Collaborators

[object Object]